Want to see ORKA full AI Analyst Report?
Oruka Therapeutics (ORKA) Income Statement
Oruka Therapeutics Income Statement
Last quarter (Q2 2026), Oruka Therapeutics's total revenue was $0.00. In Q2, Oruka Therapeutics's net income was $-41.21M. See Oruka Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -83.00K | $ -27.00K | $ -114.00K | $ -91.00K | $ -93.00K | |
| $ 121.97M | $ 88.10M | $ 9.73M | $ 19.24M | $ 9.67M | |
| Depreciation and Amortization | $ 83.00K | $ 27.00K | $ 114.00K | $ 91.00K | $ 93.00K |
| $ -105.35M | $ -82.23M | $ -9.81M | $ -19.23M | $ -9.64M | |
| $ -122.05M | $ -88.12M | $ -9.84M | $ -19.34M | $ -9.77M | |
| $ 16.62M | $ 4.40M | $ -85.00K | $ 13.00K | $ 19.00K | |
| $ -105.43M | $ -83.72M | $ -9.93M | $ -19.32M | $ -9.75M | |
| $ -105.43M | $ -83.72M | $ -9.93M | $ -19.32M | $ -9.74M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.31 | $ -4.99 | $ -8.27 | $ -16.68 | $ -8.40 |
| Diluted EPS | $ -2.31 | $ -4.99 | $ -8.27 | $ -16.68 | $ -8.40 |
| Weighted Average Shares Outstanding | 45.61M | 16.79M | 14.41M | 13.90M | 4.71M |
| Weighted Average Shares Outstanding (Diluted) | 45.61M | 16.79M | 14.41M | 13.90M | 4.71M |
Currency in USD